Transforming Cancer Detection: An Interview with Doug Cohen, CEO of IRMedtek
In this interview, we speak with Doug Cohen, CEO of IR Medtek, about their groundbreaking noninvasive cancer detection technology....
In this interview, we speak with Doug Cohen, CEO of IR Medtek, about their groundbreaking noninvasive cancer detection technology....
In the high-stakes world of pharmaceuticals, intellectual property (IP) rights are crucial for protecting innovation and ensuring returns on...
In this interview, we spoke with Farideh Bischoff, PhD, Chief Medical Officer – Head of Diagnostics at HeranovaTM, about their innovative...
In this interview, we speak with Nathalie Dubois-Stringfellow, Chief Development Officer at Sangamo Therapeutics, about the FDA’s accelerated approval...
In a conversation with Dr. Stephanie Manson Brown, Head of Clinical Development at Allergan Aesthetics, we explore the company’s initiatives to...
In this interview, we speak with Rajesh Devraj, Ph.D., President & CEO and Pol Boudes, M.D., Chief Medical Officer...
In this interview, we speak with Tim Smith, co-founder and CTO at Medable, to discuss AI’s role in addressing...
In this discussion, Moe Alsumidaie interviews Peter Schiemann, CEO and Chairman of Ymmunobio, about the company’s innovative approaches to...
In this insightful discussion, we interview Anthony Caggiano, Chief Medical Officer and Lisa Ricciardi, CEO, of Cognition Therapeutics about...
In this interview, we speak with Dr. Kuldip Dave from the ALS Association to explore their strategic approach to...